|
|Section2= }} Lipoxins are members of the family of bioactive products generated from Arachidonic Acid (AA). They have a number of immunomodulatory and anti-inflammatory actions. Lipoxins are short lived endogenously produced nonclassic eicosanoids whose appearance in inflammation signals the resolution of inflammation. They are abbreviated as LX, an acronym for lipoxygenase (LO) interaction products. At present two lipoxins have been identified; lipoxin A4 (LXA4) and lipoxin B4 (LXB4). ==History== Lipoxins were first described by Serhan, Hamberg and Samuelsson in 1984.〔 They reported that the lipoxins stimulated superoxide anion (O2−) generation and degranulation at submicromolar concentrations—as potent as LTB4. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Lipoxin」の詳細全文を読む スポンサード リンク
|